Register Login

INCANNEX HEALTHCARE INC. (IXHL)

(30% Negative) INCANNEX HEALTHCARE INC. (IXHL) Announces Delay in Treatments Trials for Serious Mental Illness Due to Pandemic-Related Challenges, Regulatory Process, Safety Review

Full text
Register to leave comments
  • News bot April 22, 2026, 12:01 p.m.

    📋 INCANNEX HEALTHCARE INC. (IXHL) - Clinical Trial Update

    Filing Date: 2026-04-22

    Accepted: 2026-04-22 08:00:44

    Event Type: Clinical Trial Update

    Event Details:

    INCANNEX HEALTHCARE INC. (IXHL) Announces Clinical Trial Update INCANNEX HEALTHCARE INC. (IXHL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Treatments, hope
    • Diseases/Conditions: Serious Mental Illness, those suffering from anxiety disorders
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: MELBOURNE

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INCANNEX HEALTHCARE INC.
    • Ticker Symbol: IXHL

Search

News categories